Skip to content
Find a data room

Industries

Data room for life sciences deals in Canada

A life sciences data room holds the regulatory, clinical, patent and manufacturing records a partner or buyer needs to value a Canadian biotech or pharma asset. It must keep trial data and unpublished patent work locked to named reviewers, log every view and support a long Q&A with scientific advisors.

Life sciences
8 yearsData protection for innovative drugs under the Food and Drug Regulations
Up to 2 yearsExtra protection from a certificate of supplementary protection

How it works in Canada

Canadian life sciences deals cluster in three places. Montreal has a deep base of contract research organizations, drug developers and pharma operations; Toronto pairs hospital research networks and the MaRS district with a large investor community; Vancouver has antibody, genomics and radiopharmaceutical companies. Most transactions are not outright sales. They are licensing deals, co-development agreements, option deals and minority investments, often with a US or European pharma partner whose diligence team works in a different time zone.

The room is read by more specialists than a typical deal. Regulatory consultants review Health Canada correspondence, clinical scientists read trial protocols and safety data, patent agents test claim scope and freedom to operate, and CMC experts look at manufacturing and quality files. A partner may spend months in the room before signing, then return after closing for milestone checks. Each group should see only its own section, and some scientific data should stay view-only until a term sheet is signed.

Canadian funding also shapes the files. Many biotechs have claimed Scientific Research and Experimental Development (SR&ED) tax credits, received provincial or federal grants with IP conditions, or licensed core technology from a university. A buyer will ask who owns each invention, which grants carry repayment or Canadian benefit terms, and whether past SR&ED claims could be reassessed by the CRA.

Best data rooms for life sciences

Our five criteria, re-weighted for this use case, plus a small bonus for providers built around it.

  1. 1 Ellty ~C$211/mo
    9.2 Visit Ellty
  2. 2 iDeals Quote
    8.9
  3. 3 Datasite Quote
    8.8
  4. 4 Intralinks Quote
    8.6
  5. 5 Ansarada Quote
    8.6
  6. 6 SmartRoom Quote
    8.6
  7. 7 Drooms Quote
    8.5
  8. 8 Firmex Quote
    8.5
  9. 9 DealRoom Quote
    8.0
  10. 10 ShareVault Quote
    8.0
Privacy 30%Workflow 21%Control 24%Usability 15%Cost 11%

What goes in the data room

Life sciences: index
  1. 01
    Corporate and capitalization

    Articles, share register, option plan, investor rights agreements and any Investment Canada notification history.

  2. 02
    Patents and freedom to operate

    Canadian, US, PCT and European filings, prosecution files, inventor assignments and any freedom-to-operate opinions kept view-only.

  3. 03
    In-licences and university agreements

    Licences from universities and hospitals, royalty stacks, sublicensing rights and change-of-control clauses.

  4. 04
    Health Canada correspondence

    Clinical trial applications, No Objection Letters, pre-submission meeting minutes and any screening deficiency notices.

  5. 05
    Clinical data

    Protocols, investigator brochures, clinical study reports and safety databases, de-identified and released in stages.

  6. 06
    Preclinical and translational

    Pharmacology, toxicology and GLP study reports with the lab or CRO that ran each one.

  7. 07
    CMC and manufacturing

    Process descriptions, CDMO supply agreements, batch records summaries, stability data and quality agreements.

  8. 08
    SR&ED and grants

    T661 claims, CRA review letters, provincial credit claims and grant agreements with IP or Canadian benefit conditions.

  9. 09
    Commercial and market access

    Pricing assumptions, PMPRB filings if marketed, provincial formulary status and distribution agreements.

  10. 10
    Employees and key scientists

    Employment and consulting agreements, invention assignment clauses and retention arrangements for named scientists.

Canadian rules that apply

Food and Drugs Act and Health Canada

Health Canada authorizes clinical trials and market access for drugs in Canada. A partner will expect clinical trial applications, No Objection Letters, Notices of Compliance, Drug Identification Numbers and inspection reports in the room, along with every deficiency letter and how it was answered.

Data protection and patent term extension

Innovative drugs can receive eight years of data protection under the Food and Drug Regulations, with an extra six months for pediatric studies. A certificate of supplementary protection can add up to two years of patent-like protection. Both affect the value of a Canadian licence.

SR&ED and grant conditions

Canadian-controlled private corporations can earn an enhanced refundable SR&ED credit on qualifying research. Buyers check the claim history, CRA reviews and whether a change of control will affect future eligibility. Grant agreements may also restrict moving IP or jobs outside Canada.

Features to insist on

Data roomQ&A moduleActivity logDynamic watermarksView and download rightsIn-room redaction
ElltyYesYesYesYesNo
iDealsYesYesYesYesYes
DatasiteYesYesYesYesYes
IntralinksYesYesYesYesYes
AnsaradaYesYesYesYesNo
SmartRoomYesYesYesYesYes
DroomsYesYesYesYesYes
FirmexYesYesYesYesYes
  • Q&A module. Bidders post questions inside the room; counsel or the CFO drafts the reply, someone approves it, and every exchange stays on file.
  • Activity log. Per-user history of opens, prints and downloads with timestamps, which you can export for the closing binder.
  • Dynamic watermarks. The reader's identity and the date are printed across every page, which discourages screenshots and identifies the source of a leak.
  • View and download rights. Choose, document by document, whether a guest may only read, may print or may download, and change it later.
  • In-room redaction. Hide social insurance numbers, pay figures or client names on the platform itself, without keeping two versions of the file.

How to set it up

  1. 1
    Split the room by discipline

    Create separate sections for regulatory, clinical, CMC, patents and commercial. Give each partner reviewer group access only to its section so the clinical team never wanders into pricing models and outside patent counsel sees only the IP folders.

  2. 2
    Stage the scientific data

    Open summaries and study synopses first. Release full clinical study reports, raw safety listings and unpublished patent applications only after a term sheet or exclusivity letter, and keep them view-only with dynamic watermarks that show the reviewer name and time.

  3. 3
    De-identify patient data

    Remove patient identifiers from case report forms and safety narratives before upload. Check provincial health privacy rules and the consent forms used in each trial, since trial participants rarely agreed to have their records shared with a commercial partner.

  4. 4
    Map the chain of title

    For each patent family, upload the inventor assignments, any university licence and a short chart showing who owns what. Partners will ask this on day one, and a clean chart saves weeks of Q&A.

  5. 5
    Route Q&A to the right expert

    Set up question categories that send regulatory questions to your regulatory lead, IP questions to patent counsel and CMC questions to the quality head. Keep answers in the room so later reviewers see them.

  6. 6
    Keep the room for milestones

    After signing, archive the deal room and keep a smaller room open for milestone reports, joint steering committee minutes and royalty statements. Licensing partnerships often run for many years, and audit rights depend on that record.

Common mistakes

  • Uploading full clinical study reports before any exclusivity, which hands a competitor bidder the most valuable data for free.
  • Missing inventor assignments from early contractors or graduate students, which leaves a gap in title that a partner will price in.
  • Forgetting that a university licence needs consent before assignment or sublicensing, then discovering it during closing.
  • Leaving trial participant identifiers inside safety narratives or site monitoring reports.

FAQ

What does a pharma partner expect to see before a licensing term sheet?

Usually a non-confidential deck, then under a confidentiality agreement a summary of Health Canada and FDA interactions, the patent estate with expiry dates, top-line efficacy and safety data and the manufacturing status. Full study reports, raw data and freedom-to-operate opinions normally wait until a term sheet or exclusivity. Staging the room this way protects your position if the talks stall.

Can we share trial participant data with a foreign partner?

Only in de-identified form in most cases. Provincial health privacy laws and the trial consent forms limit what can leave the research team, and Quebec Law 25 requires a privacy impact assessment before personal information is sent outside Quebec. Remove direct identifiers, keep the key code out of the room and record the review in your privacy file.

Do SR&ED claims matter to a buyer?

Yes. Buyers check whether past claims were reviewed by the CRA, whether any are still open and whether the change of control ends the enhanced rate that applies to Canadian-controlled private corporations. Put the T661 forms, CRA letters and your claim working papers in one folder so the tax team can review them quickly.